BCI Marketplace
Transcranial Magnetic Stimulation trials

Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS

RecruitingNCT05900271Phase: NAStarted 2023-11-15

Summary

INTRODUCTION Recent findings from three small studies (total n=59) suggest that three changes in repetitive Transcranial Magnetic Stimulation (rTMS) protocols, called the Stanford Neuromodulation Therapy (SNT) protocol, contribute to extreme high overall remission of 79% in patients with treatment resistant depression (TRD), whereas remission using a standard 10 Hz rTMS protocol is 25%. The improvement using the SNT protocol is achieved by combining 1) accelerated treatment with multiple session

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
99 Years

Inclusion Criteria: * 18 years of age or older; * Sufficient level of spoken and written Dutch; * Ability to freely provide written informed consent; * Current DSM-5 diagnosis of a depressive episode, ascertained by the Mini International Neuropsychiatry Interview (MINI-S). * A Hamilton depression

Locations

Radboud UMC
Nijmegen, GL, Netherlands
GGZinGeest
Amsterdam, North Holland, Netherlands
Amsterdam UMC location AMC
Amsterdam-Zuidoost, North Holland, Netherlands
Maastricht UMC
Maastricht, Netherlands

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →